OUR PARTNERS
CONTACT US
About
Management Team
Board of Directors
Scientific Advisory Board
Advanced Nutrition
Human Clinical Trials
Basic Research
News
Investor Relations
Overview
Analyst Coverage
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Menu
Press Releases
Overview
Analyst Coverage
News / Events
Press Releases
IR Calendar
Email Alerts
Company Information
Profile
Management Team
Presentations
IR Contacts
FAQ
Financial Information
Financials
Quarterly Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Board of Directors
Governance Docs
Email Alerts
Fact Sheet
IR Contacts
RSS News Feed
All News
By Year:
2019
2018
2017
2016
2015
2014
2013
2012
2011
Sep 29, 2016
MYOS RENS Announces Publication of Its Fortetropin(R) Human Clinical Trial Manuscript
Sep 7, 2016
MYOS RENS Technology Inc. Appoints Joseph Mannello as Interim Chief Executive Officer
Apr 22, 2016
MYOS Reports Positive Results From Fortetropin(R) Clinical Study
Mar 22, 2016
MYOS Corporation Announces Corporate Name Change to MYOS RENS Technology Inc.
Mar 8, 2016
MYOS Corporation Announces Election of New Directors and Appointment of Ren Ren as Global Chairman
Mar 4, 2016
MYOS Corporation Announces the Initial Closing of a Strategic Investment by RENS Technology Inc.
Dec 17, 2015
MYOS Corporation Announces Strategic Investment by RENS Technology Inc.
Oct 26, 2015
Maintaining Muscle Linked to Preserving Healthy Brain Tissue
Oct 19, 2015
MYOS' Proprietary Muscle Building Technology Fortetropin: Foundation for New Dietary Recommendations
Aug 14, 2015
MYOS Corporation to Host Conference Call to Discuss Management Highlights
<< Previous
1
2
3
4
5
6
7
8
9
10
...15
Next >>
Show All
